Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells

Carcinogenesis

Volumn 35, Issue 9, 2014, Pages 1983-1992

  Al Souhibani, Norah ^a   Al Ghamdi, Maha ^a   Al Ahmadi, Wijdan ^a   Khabar, Khalid S A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGIONS; AU RICH ELEMENTS; CHEMOKINE CXCL12; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HALF-LIFE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; MCF-7 CELLS; MICRORNAS; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA STABILITY; RNA, MESSENGER; TRISTETRAPROLIN;

CHEMOKINE RECEPTOR CXCR4; COLLAGENASE 3; DOXYCYCLINE; HUR PROTEIN; INTERSTITIAL COLLAGENASE; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; TRISTETRAPROLIN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; AU RICH ELEMENT; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER PATIENT; CELL MIGRATION; CHEMOTAXIS ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE SILENCING; HALF LIFE TIME; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RNA PROBE; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ZINC FINGER MOTIF;

EID: 84906837700     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu080     Document Type: Article

References (51)

1. Zhu, Q. et al. (2012) The role of CXC chemokines and their receptors in the progression and treatment of tumors. J. Mol. Histol., 43, 699-713.
2. Müller, A. et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56.
3. Domanska, U.M. et al. (2013) A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur. J. Cancer, 49, 219-230.
4. Zlotnik, A. et al. (2000) Chemokines: a new classification system and their role in immunity. Immunity, 12, 121-127.
5. Taichman, R.S. et al. (2002) Use of the stromal cell-derived factor-1/ CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res., 62, 1832-1837.
6. Zeelenberg, I.S. et al. (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res., 63, 3833-3839.
7. Burger, M. et al. (2003) Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene, 22, 8093-8101.
8. Allinen, M. et al. (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell, 6, 17-32.
9. Kato, M. et al. (2003) Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res., 5, R144-R150.
10. Scala, S. et al. (2005) Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin. Cancer Res., 11, 1835-1841.
11. Xu, T.P. et al. (2013) The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis. Cancer Epidemiol., 37, 725-731.
12. Hitti, E. et al. (2012) Sequence variations affecting AU-rich element function and disease. Front. Biosci. (Landmark Ed)., 17, 1846-1860.
13. Bakheet, T. et al. (2006) ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res., 34(Database issue), D111-D114.
14. Khabar, K.S. (2010) Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell. Mol. Life Sci., 67, 2937-2955.
15. Denkert, C. et al. (2004) Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin. Cancer Res., 10, 5580-5586.
16. Dixon, D.A. et al. (2001) Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Invest., 108, 1657-1665.
17. Niesporek, S. et al. (2008) Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression. Int. J. Oncol., 32, 341-347.
18. Al-Souhibani, N. et al. (2010) The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. Oncogene, 29, 4205-4215.
19. Young, L.E. et al. (2009) The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology, 136, 1669-1679.
20. Brennan, C.M., et al. (2009) The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res, 69, 5168-5176.
21. Lai, W.S. et al. (2006) Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol. Cell. Biol., 26, 9196-9208.
22. Al-Ahmadi, W. et al. (2013) miR-29a inhibition normalizes HuR overexpression and aberrant AU-rich mRNA stability in invasive cancer. J. Pathol., 230, 28-38.
23. Al-Ahmadi, W. et al. (2009) Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto- Regulation. Nucleic Acids Res., 37, 3612-3624.
24. Liang, Z. et al. (2005) Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res., 65, 967-971.
25. Hitti, E. et al. (2010) A versatile ribosomal protein promoter-based reporter system for selective assessment of RNA stability and post-transcriptional control. RNA, 16, 1245-1255.
26. Lai, W.S. et al. (2002) Interactions of CCCH zinc finger proteins with mRNA: non-binding tristetraprolin mutants exert an inhibitory effect on degradation of AU-rich element-containing mRNAs. J. Biol. Chem., 277, 9606-9613.
27. Rossi, D. et al. (2000) The biology of chemokines and their receptors. Annu. Rev. Immunol., 18, 217-242.
28. Tachibana, K. et al. (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature, 393, 591-594.
29. Zou, Y.R. et al. (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature, 393, 595-599.
30. Kucia, M. et al. (2005) Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1- CXCR4 axis. Stem Cells, 23, 879-894.
31. Yagi, H. et al. (2011) A synthetic biology approach reveals a CXCR4-G13- Rho signaling axis driving transendothelial migration of metastatic breast cancer cells. Sci. Signal., 4, ra60.
32. Burger, J.A. et al. (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood, 107, 1761-1767.
33. Muller, A. et al. (2006) Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. Int. J. Cancer, 118, 2147-2157.
34. Cabioglu, N. et al. (2005) Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow. Clin. Exp. Metastasis, 22, 39-46.
35. Salvucci, O. et al. (2006) The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res. Treat., 97, 275-283.
36. Koshiba, T. et al. (2000) Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin. Cancer Res., 6, 3530-3535.
37. Halees, A.S. et al. (2008) ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse. Nucleic Acids Res., 36(Database issue), D137-D140.
38. Peng, S.S. et al. (1996) Functional characterization of a non-AUUUA AU-rich element from the c-jun proto-oncogene mRNA: evidence for a novel class of AU-rich elements. Mol. Cell. Biol., 16, 1490-1499.
39. Bakheet, T. et al. (2001) ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res., 29, 246-254.
40. Xu, N. et al. (1997) Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol. Cell. Biol., 17, 4611-4621.
41. Tiedje, C. et al. (2012) The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation. PLoS Genet., 8, e1002977.
42. Qi, M.Y. et al. (2012) AU-rich-element-dependent translation repression requires the cooperation of tristetraprolin and RCK/P54. Mol. Cell. Biol., 32, 913-928.
43. Sohn, B.H. et al. (2010) Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Gastroenterology, 138, 1898-1908.
44. Griseri, P. et al. (2011) A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. Hum. Mol. Genet., 20, 4556-4568.
45. Rounbehler, R.J. et al. (2012) Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state. Cell, 150, 563-574.
46. Upadhyay, R. et al. (2013) Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival. Int. J. Cancer, 132, E128-E138.
47. Denkert, C. et al. (2006) Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod. Pathol., 19, 1261-1269.
48. Tran, H. et al. (2003) Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol. Cell. Biol., 23, 7177-7188.
49. Yuan, Z. et al. (2011) Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9. Oncol. Rep., 26, 237-245.
50. Hassan, S. et al. (2011) CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model. Int. J. Cancer, 129, 225-232.
51. Ramsey, D.M. et al. (2013) Halting metastasis through CXCR4 inhibition. Bioorg. Med. Chem. Lett., 23, 20-25.